Acetyl tetrapeptide-5
is used in cosmetic eye formulations to decrease puffiness, eye bags, and dark circles by reducing edema and protecting proteins such as SOD from glycation
Alanine
Ala / A · hydrophobic residue · neutral charge
AOD-9604
is studied as an anti-obesity peptide that can reduce weight gain and increase fat oxidation in obese animal models with generally neutral effects on IGF-1 and glucose metabolism in early human trials
Arginine
Arg / R · basic residue · positive charge
Argireline
is a topical cosmetic peptide reported to decrease dynamic wrinkles by partially mimicking the mechanism of botulinum toxin in a non-invasive manner
Asparagine
Asn / N · polar residue · neutral charge
Aspartic acid
Asp / D · acidic residue · negative charge
BPC-157
is investigated for accelerating healing of gastrointestinal mucosa, tendons, ligaments, bone, and nervous tissue in preclinical models, with anti-inflammatory and pro-angiogenic effects
Comparison
While KPV is investigated as an anti-inflammatory and barrier-protective agent in skin and mucosal models, reducing pro-inflammatory cytokines and promoting tissue repair684, Thymosin Alpha-1 is clinically used in some countries as an immunomodulator for chronic hepatitis B/C and as an adjuvant in cancer therapy, enhancing cell-mediated immunity41487.
While KPV works as the C-terminal Lys-Pro-Val tripeptide fragment of α-MSH, which exerts potent anti-inflammatory effects largely via inhibition of NF-κB signaling and modulation of cytokine expression, with many actions independent of classical melanocortin receptor activation684, Thymosin Alpha-1 is a 28-amino-acid thymic peptide fragment of prothymosin alpha that activates dendritic cells and T cells primarily via TLR9/MyD88/NF-κB signaling, enhancing Th1 responses and NK-cell cytotoxicity414.
KPV
Thymosin Alpha-1
Toll-like receptors, predominantly TLR9 (and also TLR2/TLR3) on plasmacytoid dendritic cells and other immune cells4
KPV
POMC
Thymosin Alpha-1
PTMA
Both peptides fall into a similar broad context as Immune-modulating peptides, although the details of how they are used and discussed still diverge. Both are often discussed in Immunology and inflammation contexts, while KPV is more of a signal peptide and Thymosin Alpha-1 is better described as a cytokine peptide. Both appear to work through Signaling modulator, which is one of the main reasons they can look related despite other differences. Both come from biologically derived origins and their development context also differs, with KPV in Preclinical development while Thymosin Alpha-1 is approved. Thymosin Alpha-1 incorporates acetylation features that are not part of KPV.
No related articles are linked to these peptides yet.